Michaella Corso

About Michaella Corso

I am passionate about studying technology that can potentially bring new treatment options to patients. The combination of medicine, science, and business is an area I feel fortunate to work in. The people involved all have a common goal, to help patients.Therapeutic Areas: ischemic stroke, hemorrhagic stroke, aneurysm, coronary disease, pulmonary embolism, deep vein thrombosis, acute limb ischemia, aortic stenosis (TAVR), female pelvic pain, ENTAchievements: Led global strategy and operations, growing the Clinical Affairs Department by 100+ team members Led the successful completion of over 30 clinical trials, resulting in global product approvals Implemented European MDR, gaining product clearance on 7 product families with BSI Developed and executed global clinical strategies across North America, Europe, Japan, and China Attained FDA approval for the groundbreaking transcatheter aortic valve (TAVR - SAPIEN), revolutionizing the treatment approach for aortic stenosis, significantly reducing the necessity for open heart surgeries

Experience

1. Advisor, Clinical Affairs

   Penumbra, Inc.

   Jan 2025 — Present

Education

• University of California, Los Angeles

  Bachelor of Science

Skills

• Edc
• Clinical Research
• Data Management
• Medical Devices
• Interventional Cardiology
• Clinical Monitoring
• Clinical Trials
• Fda
• Cardiology
• Ctms
• Gcp
• Clinical Development
• Cross-Functional Team Leadership
• Oncology
• Protocol
• Regulatory Affairs
• Pharmaceutical Industry
• U.s. Food and Drug Administration (Fda)
• Good Clinical Practice (Gcp)